Institutional Ownership Ani Pharmaceuticals Inc (ANIP)
This table provides information about the institutional ownership of Ani Pharmaceuticals Inc (ANIP). We have compiled data on the 239 institutions that hold shares in the stock, with a total of 20 Million shares, which have been reported (via 13F filing form) to have a value of $1.36 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
2,656,515
shares
|
$181 Million
0.0% of portfolio
|
Q2 2024
Added 4.94%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
1,181,471
shares
|
$80.4 Million
0.0% of portfolio
|
Q1 2025
Reduced 10.11%
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
818,341
shares
|
$55.7 Million
0.03% of portfolio
|
Q1 2025
Reduced 18.4%
|
|
|
Global Alpha Capital Management Ltd.
|
May 12, 2025 Q1 2025 |
735,590
shares
|
$50 Million
3.53% of portfolio
|
Q1 2025
Added 17.78%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
723,329
shares
|
$49.2 Million
0.01% of portfolio
|
Q1 2025
Added 22.27%
|
|
|
State Street Corp
Boston, MA |
May 15, 2025 Q1 2025 |
714,570
shares
|
$48.6 Million
0.0% of portfolio
|
Q1 2025
Reduced 3.08%
|
|
|
Deep Track Capital, LP
Greenwich, CT |
May 15, 2025 Q1 2025 |
700,000
shares
|
$47.6 Million
1.64% of portfolio
|
Q1 2025
Added 7.85%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Jun 26, 2025 Q1 2025 |
631,786
shares
|
$43 Million
0.01% of portfolio
|
Q1 2025
Reduced 9.7%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
May 13, 2025 Q1 2025 |
631,561
shares
|
$43 Million
0.01% of portfolio
|
Q1 2025
Reduced 7.9%
|
|
|
Ranger Investment Management, L.P.
Dallas, TX |
May 15, 2025 Q1 2025 |
571,638
shares
|
$38.9 Million
2.8% of portfolio
|
Q1 2025
Reduced 1.06%
|
|
|
William Blair Investment Management, LLC
Chicago, IL |
May 09, 2025 Q1 2025 |
528,276
shares
|
$35.9 Million
0.11% of portfolio
|
Q1 2025
Added 8.86%
|
|
|
Macquarie Group LTD
Australia, C3 |
May 15, 2025 Q1 2025 |
448,835
shares
|
$30.5 Million
0.04% of portfolio
|
Q1 2025
Reduced 20.22%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
437,453
shares
|
$29.8 Million
0.0% of portfolio
|
Q1 2025
Added 93.07%
|
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
429,626
shares
|
$29.2 Million
0.0% of portfolio
|
Q1 2025
Added 0.15%
|
|
|
Jpmorgan Chase & CO
New York, NY |
May 12, 2025 Q1 2025 |
422,750
shares
|
$28.8 Million
0.0% of portfolio
|
Q1 2025
Added 57.71%
|
|
|
Abrdn PLC
|
May 13, 2025 Q1 2025 |
419,099
shares
|
$28.5 Million
0.06% of portfolio
|
Q1 2025
Added 76.12%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 14, 2025 Q1 2025 |
390,832
shares
|
$26.6 Million
0.01% of portfolio
|
Q1 2025
Added 43.79%
|
|
|
Tang Capital Management LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
317,500
shares
|
$21.6 Million
1.38% of portfolio
|
Q4 2024
Reduced 29.44%
|
|
|
Kennedy Capital Management, Inc.
St Louis, MO |
May 13, 2025 Q1 2025 |
286,776
shares
|
$19.5 Million
0.48% of portfolio
|
Q1 2025
Added 53.95%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
264,390
shares
|
$18 Million
0.0% of portfolio
|
Q1 2025
Reduced 55.55%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
238,377
shares
|
$16.2 Million
0.0% of portfolio
|
Q1 2025
Added 0.94%
|
|
|
Thompson Siegel & Walmsley LLC
|
May 09, 2025 Q1 2025 |
237,027
shares
|
$16.1 Million
0.27% of portfolio
|
Q1 2025
Reduced 16.5%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
May 15, 2025 Q1 2025 |
229,701
shares
|
$15.6 Million
0.02% of portfolio
|
Q1 2025
Added 17.0%
|
|
|
Soleus Capital Management, L.P.
Greenwich, CT |
May 15, 2025 Q1 2025 |
224,684
shares
|
$15.3 Million
1.24% of portfolio
|
Q1 2025
Added 9.44%
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
May 14, 2025 Q1 2025 |
219,502
shares
|
$14.9 Million
0.02% of portfolio
|
Q1 2025
Added 24.86%
|